| Ashley Rogers, | |
|
3160 N Arizona Ave Ste 105, Chandler, AZ 85225-7122 | |
| (480) 365-9981 | |
| Not Available |
| Full Name | Ashley Rogers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3160 N Arizona Ave Ste 105, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538892955 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | TSLP13946 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Rogers, 111 E Peach Blossom Trl, Queen Creek, AZ 85140-5577 Ph: () - | Ashley Rogers, 3160 N Arizona Ave Ste 105, Chandler, AZ 85225-7122 Ph: (480) 365-9981 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250 million in the United States, France, Germany, Italy, Spain and the United Kingdom.
Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.
Cyanobacteria are among the most primitive living beings, aged over 3,500 million years old. These aquatic microorganisms helped to oxygenate the earth-atmosphere. At present their populations are increasing in size without stopping. It appears that global warming may be behind the rise in their numbers and may also lead toan increase in the amount of toxins produced by some of these populations.
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
› Verified 4 days ago
Ms. Heather Marie Liu, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6543 S Teresa Dr, Chandler, AZ 85249 Phone: 480-329-7600 | |
Allison Dawn Smith, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 815 E Warner Rd, Suite 106, Chandler, AZ 85225 Phone: 480-963-5800 Fax: 480-963-5805 | |
Miss Demaurice Jiana Basile, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Alicia Rowlett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3400 N Alma School Rd Apt 2034, Chandler, AZ 85224 Phone: 719-671-7172 | |
Gail Cisneros, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Gabrielle Christine Goldsmith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 964 E Cherry Hills Dr, Chandler, AZ 85249 Phone: 509-217-3367 | |
Lauren Mead, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 |